The association between lung function and exacerbation frequency in patients with COPD, results from a systemic review

M. Hoogendoorn, T. Feenstra, R. Hoogenveen, M. Rutten-van Mölken (Rotterdam, Bilthoven, Netherlands)

Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Session: Exacerbations and characteristics of COPD
Session type: Thematic Poster Session
Number: 985
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Hoogendoorn, T. Feenstra, R. Hoogenveen, M. Rutten-van Mölken (Rotterdam, Bilthoven, Netherlands). The association between lung function and exacerbation frequency in patients with COPD, results from a systemic review. Eur Respir J 2009; 34: Suppl. 53, 985

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Differences in systemic immune function contribute to exacerbation susceptibility in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015


Preliminary results of relationship between appetite and clinical presentation of COPD patients in AERIS study
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


A clinical study of lung cancer cases with underlying COPD in relation to the COPD phenotype
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010


The relationship between comorbidities and systemic inflammation in patients with COPD
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

The positive effect of cilomilast on lung function in patients with chronic obstructive pulmonary disease (COPD) is independent of patient smoking status
Source: Eur Respir J 2002; 20: Suppl. 38, 620s
Year: 2002

Longitudinal changes in the nature, severity and frequency of COPD exacerbations
Source: Eur Respir J 2003 Dec 01;22(6):931-936
Year: 2003



Baseline data and responses to oral steroid intervention in asthma and COPD: interim report from the BIOAIR EU study
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007



The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014

Airways and systemic inflammation and correlation to lung function in smokers and in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 651s
Year: 2006

A retrospective evaluation of lung function and exacerbations in COPD patients-RETRIEVE study.
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021


Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005


Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007


Association of systemic inflammation with clinical recovery in patients with acute exacerbation of COPD
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011


Early discharge for patients with exacerbations of COPD - a real life cohort study
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005


The effect of methlyxanthines as adjunct to corticosteroids among chronic obstructuve pulmonary disease patients in acute exacerbation: a systematic review and meta-analysis
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


The relationship of exacerbations and lung function decline to radiologic characteristics in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005

The impact of vaccination on the dynamics of bronchial and systemic inflammation in patients with COPD and CHD
Source: International Congress 2017 – COPD management
Year: 2017


Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013



COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD
Source: ERJ Open Res, 7 (1) 00718-2020; 10.1183/23120541.00718-2020
Year: 2021



The effectiveness of early pulmonary rehabilitation in acute exacerbation of COPD in the terms of functional and systemic markers.
Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation
Year: 2020